Total Clarity Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Total Clarity Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15	Closed	-$1K	–	1053
2022 Q2	$1K	Buy	+15	New	+$1.42K	﹤0.01%	1009
2022 Q1	–	Sell	-15	Closed	-$2K	–	999
2021 Q4	$2K	Sell	15 -100	-87%	-$10.9K	﹤0.01%	939
2021 Q3	$13K	Buy	+115	New	+$11.9K	0.01%	625
2021 Q2	–	Sell	-15	Closed	-$1K	–	831
2021 Q1	$1K	Buy	+15	New	+$1.27K	﹤0.01%	814

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Total Clarity Wealth Management's HZNP Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 15 shares — an estimated $1K sold.

Total Clarity Wealth Management first reported a position in HZNP in Q1 2021 and held it in 4 quarters. The position peaked at $13K in Q3 2021. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Total Clarity Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 15 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $1K.
Total Clarity Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 4 quarters.
Total Clarity Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $13K in Q3 2021.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.